Osborne Clarke advised Ducker Carlisle on the deal, while the US legal aspects of the transaction were advised by Ballard Spahr LLP. Ducker Carlisle, a portfolio...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr and Ballard Spahr advised New York Times in the case. On April 22, the New York Times secured a victory...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Charlesbank Capital Partners, while Ballard Spahr advised Boathouse Capital in the transaction. IMPLAN Group LLC (“IMPLAN” or the...
You must be a Standard 1 Year member to access this content.
Ballard Spahr served as lead counsel to CoStar Group. CoStar Group—a leading commercial real estate information, analytics, and news platform— announced its purchase of the 31-story...
You must be a Standard 1 Year member to access this content.
Ballard Spahr assisted RhythMedix on the sale. Pharos Capital Group has acquired a majority stake in New Jersey-based RythMedix, a manufacturer and provider of remote cardiac...
You must be a Standard 1 Year member to access this content.
Ballard Spahr assisted 3Helix on the round. BASF and 3Helix Inc., a U.S.-based technology start-up, announced their innovation partnership on 3Helix’s proprietary CHP technology. The partnership...
You must be a Standard 1 Year member to access this content.
Ballard Spahr served as Wells Fargo Securities and other underwriters’ counsel. City of Philadelphia announced a $91 million project to replace all of its 130,000 streetlights—the largest energy...
You must be a Standard 1 Year member to access this content.
Ballard Spahr advised TESSCO Technologies Incorporated on the deal. Leading wireless products supplier TESSCO Technologies Incorporated announced itsmerger with entities affiliated with Lee Equity Partners and...
You must be a Standard 1 Year member to access this content.
Ballard Spahr represented Stony Brook University on the deal. Stony Brook University (SBU) announced its successful public-private partnership (P3) proposal to lead a consortium of academic institutions...
You must be a Standard 1 Year member to access this content.
Ballard Spahr represented OMERS Life Sciences on the deal. Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral...
You must be a Standard 1 Year member to access this content.
Ballard Spahr represented AJNA BioSciences PBC on the deal. AJNA BioSciences PBC announced the formation of a drug-development joint venture with Charlotte’s Web, Inc (TSX: CWEB), the...
You must be a Standard 1 Year member to access this content.
Ballard Spahr represented Green Development, LLC on the deal. Green Development, LLC announced the sale of a 26.2-megawatt portfolio of operating solar assets in Rhode Island....
You must be a Standard 1 Year member to access this content.
